These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10283250)

  • 1. Vaccine-related injuries: alternatives to the tort compensation system.
    Sturges SA
    Spec Law Dig Health Care (Mon); 1987 Aug; 9(2):7-36. PubMed ID: 10283250
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. Fixing America's vaccine system.
    McCormick K
    Mcgraw Hills Med Health; 1988 Oct; 42(43):suppl 4 p.. PubMed ID: 10290195
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine-related injuries: alternatives to the tort compensation system.
    Sturges SA
    St Louis Univ Law J; 1986; 30(3):919-48. PubMed ID: 11649882
    [No Abstract]   [Full Text] [Related]  

  • 4. Elements of causation in toxic tort litigation. Science and law must agree.
    Benjamin DM
    J Leg Med; 1993 Mar; 14(1):153-65. PubMed ID: 8463748
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug safety: a contrarian's point of view.
    Cobert B
    Food Drug Law J; 2007; 62(3):501-12. PubMed ID: 17915392
    [No Abstract]   [Full Text] [Related]  

  • 6. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug product liability and health care delivery systems.
    Sage WM
    Stanford Law Rev; 1988 Apr; 40(4):989-1026. PubMed ID: 10318110
    [No Abstract]   [Full Text] [Related]  

  • 8. An experiment in Tort reform.
    Flamberg G
    Public Health Rep; 1995; 110(5):635-8. PubMed ID: 7480621
    [No Abstract]   [Full Text] [Related]  

  • 9. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
    Carrier MK
    Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729
    [No Abstract]   [Full Text] [Related]  

  • 10. An immodest proposal.
    Dunn RR
    Soc Policy; 1983; 13(3):27-8. PubMed ID: 10260488
    [No Abstract]   [Full Text] [Related]  

  • 11. The export of hazardous products and industries: a bibliography.
    MacSheoin T
    Int J Health Serv; 1985; 15(1):145-55. PubMed ID: 3882585
    [No Abstract]   [Full Text] [Related]  

  • 12. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons learned from good manufacturing practice noncompliance.
    Peskoe MP
    Food Drug Law J; 1995; 50(1):65-70. PubMed ID: 10342986
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 15. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 16. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848.
    Heath WJ
    Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 18. A national compensation program for vaccine-related injuries.
    Karzon DT
    N Engl J Med; 1984 May; 310(20):1320-2. PubMed ID: 6717496
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 20. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.